Unknown

Dataset Information

0

Cryptogenic stroke and patent foramen ovale (abridged and translated version).


ABSTRACT: Interventional patent foramen ovale (PFO) closure should be performed in patients aged 16 to 60?years (after extensive neurological and cardiological diagnostic work-up) with a history of cryptogenic ischaemic stroke and patent foramen ovale, with moderate or extensive right-to-left shunt. In patients with cryptogenic ischaemic stroke and patent foramen ovale, who reject a PFO closure, there is no evidence of superiority of oral anticoagulation over antiplatelet therapy. Therefore, secondary prevention should be performed with aspirin or clopidogrel. Atrial fibrillation, pericardial tamponade, and pulmonary embolism are reported complications during and after implantation of an occluder. However, these events are so rare that they should not influence the recommendation for implantation. This article is an abridged and translated version of the guideline published in Nervenarzt: Diener, HC., für die Deutsche Gesellschaft für Neurologie (DGN), Grau, A.J. et al. Nervenarzt (2018) 89: 1143. 10.1007/s00115-018-0609-y.

SUBMITTER: Diener HC 

PROVIDER: S-EPMC7650129 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cryptogenic stroke and patent foramen ovale (abridged and translated version).

Diener Hans-Christoph HC   Grau Armin A   Baldus Stephan S  

Neurological research and practice 20190228


Interventional patent foramen ovale (PFO) closure should be performed in patients aged 16 to 60 years (after extensive neurological and cardiological diagnostic work-up) with a history of cryptogenic ischaemic stroke and patent foramen ovale, with moderate or extensive right-to-left shunt. In patients with cryptogenic ischaemic stroke and patent foramen ovale, who reject a PFO closure, there is no evidence of superiority of oral anticoagulation over antiplatelet therapy. Therefore, secondary pre  ...[more]

Similar Datasets

| S-EPMC2764355 | biostudies-literature
| S-EPMC4248455 | biostudies-literature
| S-EPMC6318108 | biostudies-literature
| S-EPMC5915909 | biostudies-literature
| S-EPMC3775694 | biostudies-literature
| S-EPMC10037544 | biostudies-literature
| S-EPMC8015114 | biostudies-literature
| S-EPMC7891282 | biostudies-literature
| S-EPMC9524620 | biostudies-literature
| S-EPMC5353430 | biostudies-other